Financials of Concord Biotech Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Concord Biotech Ltd

Quarterly Results

Quarter-by-quarter operating performance

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales +241273195262241319216310244430204247278
Expenses +129144123143135185135174146239143157176
Operating Profit1121297211910613481137981906191102
OPM %46%47%37%45%44%42%38%44%40%44%30%37%37%
Other Income +91278811101015914137
Interest1111000000000
Depreciation14141313141413131315181819
Profit before tax106126651131001317813399185578690
Tax %26%26%25%25%26%26%25%26%25%23%26%26%25%
Net Profit +799448847597589974142436368
EPS in Rs7.568.944.638.087.139.295.579.437.0813.574.076.016.48

Financials of Concord Biotech Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales +2392763404365126177138531,0171,2001,159
Expenses +133145212256308289439509585693714
Operating Profit105131127180205328274344432507445
OPM %44%48%37%41%40%53%38%40%42%42%38%
Other Income +118361731142335344443
Interest10111165310
Depreciation1010181921285054545469
Profit before tax106129144178213313241320409496418
Tax %34%33%30%33%21%25%26%26%26%25%
Net Profit +7087100118169235179238305373315
EPS in Rs76.3294.78105.66124.48177.65247.44187.7622.7629.1335.6530.13
Dividend Payout %22%25%0%21%22%0%3%30%30%25%

Financials of Concord Biotech Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital99101010101010101010
Reserves2683295856737619901,0981,2821,5151,8021,815
Borrowings +3536229528962321032
Other Liabilities +5574697111894144191164219194
Total Liabilities3674486857639411,1831,3131,5151,6992,0342,021
Fixed Assets +104110189230240546573593575795790
CWIP197031914118741732115174
Investments424315122919914274138244335354
Other Assets +202225343285361477592611668854804
Total Assets3674486857639411,1831,3131,5151,6992,0342,021

Financials of Concord Biotech Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +79155167207246265245
Cash from Investing Activity +-42-114-195-112-158-155-160
Cash from Financing Activity +-37-4331-100-85-99-99
Net Cash Flow0-13-4312-14
Free Cash Flow79-1-3752101180134
CFO/OP101%100%74%98%92%85%70%

Financials of Concord Biotech Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days165182236133131105119117125159
Inventory Days276321381310312503434430331286
Days Payable108129210112201152185190150135
Cash Conversion Cycle334374407331242456368357306310
Working Capital Days195209275177159177163153166193
ROCE %37%25%25%32%21%26%28%28%